PATENT CLAIM ANALYSIS

Application Number: 16233890
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "100000"]

Abstract:
The present invention relates to a glucagon derivative, a conjugate thereof, and a composition comprising the same, and a therapeutic use thereof, and in particular, for metabolic syndrome, hypoglycemia, and congenital hyperinsulinism.

Claim (Index 59):
An isolated peptide, which comprises the amino acid sequence of the following General Formula 2: (SEQ\u2003ID\u2003NO:\u200346) Y-Aib-QGTF-X7-SD-X10-S-X12-Y-L-X15-X16-X17-R-A- X20-X21-F-V-X24-W-L-M-N-T-X30 General Formula 2 wherein\n X7 is threonine (T), valine (V), or cysteine (C); \n X10 is tyrosine (Y) or cysteine (C); \n X12 is lysine (K) or cysteine (C); \n X15 is aspartic acid (D) or cysteine (C); \n X16 is glutamic acid (E) or serine (S); \n X17 is lysine (K) or arginine (R); \n X20 is glutamine (Q) or lysine (K); \n X21 is aspartic acid (D) or glutamic acid (E); \n X24 is valine (V) or glutamine (Q); and \n X30 is cysteine (C) or is absent.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.48148
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15740668', '13810999', '16024014', '15313501', '15086499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8061678716524727
- 35 USC 102 Novelty (BERT): 0.6893658851920411
- Combined Prediction Score: 0.7944876730064296
- Mean Citation Score: 452.842674
- Max Citation Score: 747.8688
- Similarity Product: 683.5586170383452

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test